Six things to tell patients about the Delta variant of SARS-CoV-2Spreads faster than early forms of SARS-CoV-2 and is now the predominant variant in Canada and the United States One jab has almost no effect against Delta: studyAccording to a recently published study, two shots are better than one when it comes to protection against the SARS-CoV-2 Delta, as well as other, variants of the virus. J&J: Potential HIV vaccine falls short in mid stage study The study in sub-Saharan Africa involved about 2,600 women who were deemed to be at high risk of acquiring HIV, which causes AIDS. Ontario's Vaccine Clinical Advisory Group recommends some cohorts receive third mRNA vaccine The update outlines the specific populations who would most benefit from a third or booster shot. Health Canada considering new oral antiviral for treatment of COVID-19 Merck’s molnupiravir is a twice-daily oral antiviral agent currently under study as a potential treatment for mild/moderate COVID-19. Be alert for dermatologic conditions related to COVID-19 Skin conditions may be directly related to COVID-19, or indirectly related due to use of personal protective equipment and frequent sanitization. Prolonged COVID complications rare in kids, but experts say more studies needed With schools reopening soon, Canadian parents are worried infections among children will soar. Mixed messages for travellers cause confusion While rules around mixed dosing are slowly being made more consistent, healthcare professionals should continue to reassure patients that they did the right thing by becoming fully-vaccinated. Nudging patients with texts improves vaccine uptake A short text reminder may be all it takes to get patients to book their COVID-19 vaccines, show results of a large study. Mixed messages for travellers Pharmacists can help clear confusion for patients who travel First Previous 48 49 50 51 52 Next Last
